|
ISPE Events
Guidance Documents
Training
Pharmaceutical Engineering Magazine
eLearning
Publications
Glossary
|
Young Professionals
Affiliates and Chapters
Advertise/Exhibit
Communities of Practice
Regulators
Volunteers
Students
International Leadership Forum
|
CPIP - Professional Certification
Employers
Job Seekers
|
ISPE Glossary of Pharmaceutical and Biotechnology Terminology
| Browse All Terms | |
| Beginning With | By Language |
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z :: All |
English Deutsch Francais |
Hybridoma
A hybrid cell resulting from the fusion of a specific antibody producing spleen cell with a myeloma cell. The hybrid cell has the growth characteristics of the myeloma component and the antibody secreting characteristics of the spleen cell and will multiply to become a source of large quantities of pure, monoclonal antibody.
Hybridoma
An immortalized cell line (usually derived by fusing B-lymphocyte cells with myeloma tumor cells) that secretes a desirable protein, typically a monoclonal antibody.
Publication Source: ISPE Baseline® Guide, Vol. 6: Biopharmaceutical Manufacturing Facilities
Publication Date: 2004
Do you have a term that should be included in the glossary?
Submit a term for review
My ISPE
